Akèy › Kansè poumon › Pennsylvania › Reading
Etid klinik pou Kansè poumon nan Reading, PA
11 etid pou Kansè poumon ap chèche patisipan nan sit nan ak bò kote Reading (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Reading Hospital, West Reading · 1 mi lwen
- Ephrata Cancer Center, Ephrata · 17 mi lwen
- Sechler Family Cancer Center, Lebanon · 26 mi lwen
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Penn State Health Saint Joseph Medical Center, Reading
- Reading Hospital, West Reading · 1 mi lwen
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Ap rekriteFaz 3
- Reading Hospital, West Reading · 1 mi lwen
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Ap rekriteFaz 3
- Ephrata Cancer Center, Ephrata · 17 mi lwen
- Sechler Family Cancer Center, Lebanon · 26 mi lwen
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Ap rekriteFaz 3
- Reading Hospital, West Reading · 1 mi lwen
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Reading Hospital - McGlinn Cancer Institute, West Reading · 1 mi lwen
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Reading Hospital, West Reading · 1 mi lwen
- Ephrata Cancer Center, Ephrata · 17 mi lwen
- Sechler Family Cancer Center, Lebanon · 26 mi lwen
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Ephrata Cancer Center, Ephrata · 17 mi lwen
- Sechler Family Cancer Center, Lebanon · 26 mi lwen
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Ephrata Cancer Center, Ephrata · 17 mi lwen
- Sechler Family Cancer Center, Lebanon · 26 mi lwen
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2/3
- Ephrata Cancer Center, Ephrata · 17 mi lwen
- Sechler Family Cancer Center, Lebanon · 26 mi lwen
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Ap rekriteEtid obsèvasyon
- US Digestive Health at Wyomissing, Wyomissing · 2 mi lwen
Etid Kansè poumon nan lòt vil
- Houston, TX78 etid
- Boston, MA62 etid
- New York City, NY60 etid
- Los Angeles, CA45 etid
- Washington, DC41 etid
- Arlington, VA41 etid
- Chicago, IL41 etid
- Nashville, TN40 etid
- Baltimore, MD40 etid
- St. Louis, MO39 etid
- Columbus, OH37 etid
- Philadelphia, PA36 etid
Lòt etid nan Reading
- Kansè Poumon ki pa ti selil9 etid
- Leksemi mieloïd egi5 etid
- Kansè nan tete5 etid
- Twoub Somnolans Eksestif5 etid
- Kansè pwostat4 etid
- Kansè (tout kalite)4 etid
- Kansè kolorektal3 etid
- Nakolepsi3 etid
- Twoub dòmi3 etid
- Fatig3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.